Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma.

Corazzelli, Gaetano

Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma. [electronic resource] - British journal of haematology Jan 2013 - 207-15 p. digital

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1365-2141

10.1111/bjh.12120 doi


Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Agents, Alkylating--adverse effects
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Bendamustine Hydrochloride
Cell Cycle Checkpoints--drug effects
Combined Modality Therapy
DNA Repair--drug effects
Disease-Free Survival
Drug Evaluation
Female
Hematologic Diseases--chemically induced
Hematopoietic Stem Cell Transplantation
Hodgkin Disease--drug therapy
Humans
Male
Middle Aged
Nitrogen Mustard Compounds--adverse effects
Off-Label Use
Recurrence
Retrospective Studies
Salvage Therapy
Transplantation, Homologous
Treatment Outcome
Young Adult